Fotios Barkas/ LinkedIn
Sep 1, 2025, 07:37
Fotios Barkas Highlights Key Updates in ESC2025 Dyslipidemia Guidelines
Fotios Barkas, Assistant Professor of Internal Medicine University of Ioannina, shared a noteworthy post on LinkedIn:
“Just released in ESC2025: Updated Dyslipidemia Guidelines
Key highlights:
- CAC Score for risk
- LDL-C cutoffs for LLL initiation
- Bempedoic acid and Evinacumab
- Lp(a) ≥50 mg/dL as a cutoff
- Intensification of LLM post-ACS
- EPA only
- Volanesorsen in FCS, statins in HIV, and anthracyclin-induced cardiotoxicity
- Dietary supplements”
Stay updated with Hemostasis Today.
Bempedoic Acid
CAC Score
Cardiotoxicity
cardiovascular risk
Dietary Supplements
Dyslipidemia Guidelines
EPA
ESC 2025
European Atherosclerosis Society
Evinacumab
Familial Chylomicronemia Syndrome
Health
Hematology
Hemostasis Today
HIV
LDL Cholesterol
Lipid Lowering Therapy
Lipoprotein a
Medicine
Post ACS Management
statins
Volanesorsen
-
Apr 23, 2026, 14:46Mital Jhaveri: Anticoagulant Approval and Uptake Timeline
-
Apr 23, 2026, 14:42Salih Ehsan: Bradykinin-Mediated Transfusion Reactions in Patients on ACE Inhibitors
-
Apr 23, 2026, 14:39Mona Alfaraj: Don’t Miss the Chance to Be Part of the 2nd International Hematology and Hemostasis Conference
-
Apr 23, 2026, 14:11Emerging Contributions to Hemostasis from Recipients of the Christine Lee Young Researcher Awards – WFH
-
Apr 23, 2026, 13:52Joffrey Feriel: A Revised ISTH Definition of Disseminated Intravascular Coagulation
-
Apr 23, 2026, 13:39Mazou Ngou Temgoua: Cancer and VTE – Toward Truly Personalized Anticoagulation
-
Apr 23, 2026, 13:35Jecko Thachil: Risk Assessment and Clinical Management of Nephrotic Syndrome–Associated Thrombosis
-
Apr 23, 2026, 12:18Mona Ranade: A Contemporary Framework for Managing Right Heart Thrombus in PE
-
Apr 23, 2026, 11:59Strengthening Hemophilia Care Through Collaboration and Commitment in India at IHC X 2026 – Hemophilia Federation India